Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew J. Murphy currently holds 47,833 shares of REGENERON PHARMACEUTICALS, INC. (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Murphy has been a net seller of REGN stock. They have purchased $0 and sold $57.6M worth of shares.
Andrew J. Murphy's most recent insider trade was on Dec 9, 2025, when they sold 4,229 shares at $701.51 per share.
Andrew J. Murphy serves as Executive at REGENERON PHARMACEUTICALS, INC. (REGN). They have executed 260 insider transactions totaling $57.6M over their tenure at the company.
Andrew J. Murphy holds the position of Executive at REGENERON PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Andrew J. Murphy has shown a selling trading pattern, with $0 in total purchases and $57.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew J. Murphy was on Oct 29, 2025, when they sold $21.1M worth of REGN shares. This transaction involved 32,490 shares at $648.82 per share.
Andrew J. Murphy currently owns 47,833 shares of REGENERON PHARMACEUTICALS, INC. (REGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew J. Murphy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew J. Murphy has 260 Form 4 filings on record as an insider at REGENERON PHARMACEUTICALS, INC..
Set alerts for Andrew J. Murphy and 40,000+ other insiders.